To the shareholders of ADC Therapeutics SA Invitation to the Annual General Meeting Date and Time: Wednesday, June 14, 2023, at 4:00 a.m. EDT / 10:00 a.m. CEST . | May 5, 2023
WATERTOWN, Mass., Nov. 03, 2022 Kymera Therapeutics, Inc. , a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader. | November 3, 2022